TNGX Tango Therapeutics Net earnings per share growth this year

TNGX (Tango Therapeutics) - company brandmark

Tango Therapeutics (TNGX) develops R&D projects through alliances with pharma giants, excluding mergers. The business relies on a synthetic lethality platform that creates unique patent perimeters. The synergy of these factors and a qualified staff of oncologists determine the annual EPS growth rate, where the current value is -72.60, demonstrating the company's efficiency dynamics.

Tango Therapeutics, Inc. (TNGX): Net earnings per share growth this year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Tango Therapeutics Corp (TNGX)

- current quotes and average value forecast:
Summary company analysis:TNGX (Tango Therapeutics)
Brand item of Tango Pharma

For Tango Therapeutics (TNGX), as an R&D startup with oncology partnerships, profit dynamics are secondary to clinical trial progress. By analyzing the 12-month EPS growth percentage, an investor assesses the annual change in net income per share, which allows this chart to track cost management efficiency and the sustainability of the financial trend in the absence of commercial sales.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Iovance Biotherapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Immatics Biotechnologies IMTX|XNCR - Earnings per share growth in current year|CMPX (compasstherapeutics.com) - Earnings per share growth this year|Replimune Inc. (REPL) - Earnings per share growth in current year|Earnings per share growth rate in current year Lyell Immunopharma Inc (LYEL)|Net earnings per share growth this year IPHA|PYXS - Net earnings per share change in current year|Net earnings per share growth this year CGEN (Compugen Ltd.)|Net earnings per one share growth for the current year IOBT|Earnings growth in current year STRO (Sutro Biopharma)|Earnings per share increase in current year INKT|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year